USPTO serial 97410225
JIXING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABRAMS, JACQUELINE WILLETTE
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with JIXING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Emilia F. Cannella
EMILIA F. CANNELLA ROPES & GRAY LLPPRUDENTIAL TOWER, 800 BOYLSTON STREETBOSTON, MA 02199UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Human medicine, Pharmaceutical formulation, Chemical pharmaceutical formulation, Medical ointment, Bronchiectasis formulation, Injection, Tablet, Tincture, Water-based, Ointment, Drugs for the treatment of infectious diseases, Pharmaceutical formulation for the treatment of hypercholesterolemia, Pharmaceutical formulation for the treatment of hyperlipidemia, Pharmaceutical formulation for the treatment of asthma, Cholesterol lowering agents, Blood pressure medication, Antidiabetic drugs, Antidiabetic formulation, Antiarrhythmic formulation, Cardiovascular pharmaceutical formulation, Medical formulation for eye or intraocular surgery, Pharmaceutical products for ophthalmic use, Ophthalmic formulation, Eye formulation, Cardiovascular drugs for medical purposes, Inhaled medical formulation used for the treatment of pulmonary hypertension | ACTIVE | — |
| 042 | Scientific research and development; Drug development services; Drug research services, Development of pharmaceutical formulation and medicines, Biomedical research services, Medical research services, Chemical Research; Biotechnology research, Drug testing; Software as a Service (SaaS) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 16, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 16, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 16, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 31, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 17, 2022 | NWAP | NEW APPLICATION ENTERED | — |